Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-17

FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for chlordiazepoxide hydrochloride from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlordiazepoxide hydrochloride (Chlordiazepoxide hydrochloride)

Snippet

SUPPL AP for CHLORDIAZEPOXIDE HYDROCHLORIDE (CHLORDIAZEPOXIDE HYDROCHLORIDE)